Educational Activities Archives

Filter by Target Audience Information
Filter by Target Audience

Please select the option that best aligns with your profession.

Target Audience
Filter by Topic Information
Filter by Topic

Please select the option that best aligns with your topic of interest.

Click on the plus (+) icon to display subtopics.

Training Courses – Full Topics Checkboxes
Filter by Format Information
Filter by Format

Please select the option that best aligns with your preferred format of training.

Formats
Key Term Search Information
Key Term Search

Use the search bar to enter in the title of a training, or other key terms.

Course and Resource Listing

Back to Filter ^

Talking Things Pharmacists Need to Know about Urine Drug Monitoring

Format: Podcast
Controlled substances, including opioids, benzodiazepines, and medical cannabis, are commonly prescribed for the treatment of chronic pain. Urine drug screens (UDS) are often used in clinical practice to test for the presence of prescribed drugs to monitor compliance. Understanding how to appropriately interpret the results of urine drug screening is critical to providing effective patient care and maintaining patient trust. Pharmacists in various practice settings can play important roles in urine drug screenings.
Target Audience(s):
Pharmacists
Topic(s):
Professional Health Programs, Laboratory, Medications, Opioids, Pharmacist Health Programs, Screening and Assessment, Treatment, Urine Toxicology / Drug Screens ...
Presenter(s):
Emily Leppien, PharmD BCPS, and Todd Eury
Credit Available:
CE Credit(s): No
Certificate: No
Organizer(s):
American Pharmacists Association

Substance Use Disorders

Format: Clinical Tool
Psychiatric pharmacists are advanced practice clinical pharmacists committed to being part of an interdisciplinary team treating substance use disorders, often in combination with serious mental illness. The following SUD toolkits were developed to further the knowledge of pharmacists and other healthcare professionals.
Target Audience(s):
Pharmacists, Interprofessional Teams, Pharmacy Technicians
Topic(s):
Co-Occurring Addiction / Psychiatric, Acamprosate, ADHD, Agonist / Partial Agonist Withdrawal, Alcohol, Alcohol, Amphetamines, Anxiety Disorders, Benzodiazepines, Buprenorphine ...
Credit Available:
CE Credit(s): No
Certificate: No
Organizer(s):
American Association of Psychiatric Pharmacists

Behavioral Interventions for Substance Use Disorders: Improving Outcomes

Format: Module
As we enhance our understanding of addiction medicine through research, we strive to improve the treatment outcomes for our patients. Substance Use Disorder (SUD) at its core is an effective combination treatment because although medication is extremely beneficial in the treatment of addictions, for many patients it is not sufficient to maintain recovery because it does not address the behavioral aspects of the disease of addiction. This module provides basic information on 4 Evidence-Based Practices (EBPs) that effectively treat the behavioral aspects of the disease of addiction. This module includes examples of techniques that may be performed during medication management and/or longer counseling visits with patients.
Target Audience(s):
Nurses, Interprofessional Teams, PAs, Pharmacists, Physicians, Social Workers
Topic(s):
Basic Science, Brief Intervention, Co-Occurring Addiction / Psychiatric, Co-Occurring SUD / Medical Disorders, Cognitive Behavioral, Collaborative Care Motivation Enhancement, Education (Addiction Psychiatry / Addiction Medicine), Implementation, Mutual Supports, Peer Support ...
Presenter(s):
Stacey Conroy, LICSW, MPH
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Creditâ„¢, AAPA Category 1 CME, Social Work CE Credit, Nursing Contact Hours, Pharmacy CE Credit, Interprofessional Continuing Education (IPCE) Credit
Organizer(s):
American Academy of Addiction Psychiatry

Practice-Based Guidelines: Buprenorphine in the Age of Fentanyl (PCSS-MOUD Guidance)

Format: Clinical Tool
The purpose of this guide is to provide practical clinical practice-based guidance, based on available research combined with emerging clinical experience, on the use of buprenorphine in the treatment of individuals using fentanyl and other highly potent synthetic opioids. 
Target Audience(s):
Dentists, Interprofessional Teams, Nurses, PAs, Pharmacists, Pharmacy Technicians, Physicians, Psychiatrists, Psychologists, Social Workers, Students and Educators
Topic(s):
Basic Science, Antagonist, Buprenorphine, Buprenorphine, Full Agonists, Laboratory, Medications, Methadone, Methadone, Naltrexone ...
Credit Available:
CE Credit(s): No
Certificate: No

NIDA Chart of Evidence-Based Screening Tools and Assessments for Adults and Adolescents

Format: Clinical Tool
Screening and Assessment Tools Chart.
Target Audience(s):
Psychologists, Nurses, PAs, Physicians, Psychiatrists, Social Workers, Students and Educators
Topic(s):
Screening and Assessment, Assessment, DSM-5, Screening and Brief Intervention, Screening Tools ...
Credit Available:
CE Credit(s): No
Certificate: No

Substance Use Screening, Brief Intervention, and Referral to Treatment

Format: Clinical Tool
The enormous public health impact of adolescent substance use and its abstract preventable morbidity and mortality highlight the need for the health care sector, including pediatricians and the medical home, to increase its capacity regarding adolescent substance use screening, brief intervention, and referral to treatment (SBIRT).
Target Audience(s):
Students and Educators, Physicians, Psychiatrists
Topic(s):
Screening and Assessment, Adolescents, Pediatrics / Adolescent, Screening, Screening and Brief Intervention, Treatment ...
Credit Available:
CE Credit(s): No
Certificate: No
Organizer(s):
American Academy of Pediatrics
More Results